Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date New Mechanisms and Emerging Treatment Options in Metastatic Breast CancerEducation Oncology All Addressing Knowledge Gaps in Aplastic AnemiaRelease Date:Education Hospital All Gene and Gene-modified Cell Therapies Medical EducationRelease Date:Partner: American Society of Gene + Cell TherapyEducation Rare Disease All Education for Improvement of Early Detection and Appropriate Anticoagulant Therapy for Atrial FibrillationRelease Date:Education Internal Medicine Japan Efforts to Improve Quality of Migraine Medical CareRelease Date:Partner: The Japanese Headache SocietyEducation Internal Medicine Japan Pathological diagnosis and Immunohistochemistry biomarker assessments of Breast CancerRelease Date:Quality Improvement Oncology Ghana Evolving Treatment Options in First-line Metastatic Urothelial Carcinoma (mUC) and Muscle Invasive Bladder Cancer (MIBC)Education Oncology All Promoting Understanding of COVID-19 and Vaccination and Improving Communication Skills for Healthcare ProfessionalsRelease Date:Quality Improvement Vaccines Japan American Headache Society Quality Improvement Competitive Grant ProgramQuality Improvement Internal Medicine USA Boosting Oncology Opportunities for Support programs and Treatment, (BOOST), An Oncology Quality Boosting ProgramRelease Date:Quality Improvement Oncology Netherlands Understanding the Mechanisms and Formulating the Optimal Management of Hematological Toxicity of PARPiRelease Date:Partner: National Comprehensive Cancer NetworkResearch Oncology USA Improving Care for Patients with Recurrent/Metastatic (R/M) Cervical CancerRelease Date:Education Oncology USA